Peptide News Digest

#Epilepsy

2 stories

Research · View digest

Tübingen Researchers Find a Scorpion-Toxin Peptide That Blocks One Potassium Channel Has Little Effect on Real Neurons

Neurologists at the University of Tübingen's Hertie Institute reported in Frontiers in Pharmacology on October 13, 2026 that BMK86-P1, a synthetic scorpion-toxin peptide, selectively blocked Kv1.2 potassium channels made only of Kv1.2 units in cells but barely affected channels mixed with Kv1.1, the form common in the brain. In mouse neurons it produced little change in firing or synaptic activity. The authors, who study gene variants in these channels that cause epilepsy, said the work shows the limits of using such toxins as precise research tools.

Research · View digest

Apoptin-Derived Peptide B9 Cuts Seizure Susceptibility and Improves Memory in Mouse Models of Temporal Lobe Epilepsy

Researchers at Harbin Medical University reported in CNS Neuroscience & Therapeutics, published online October 1, 2026, that B9, a peptide derived from the viral protein apoptin, lowered seizure susceptibility, reduced epileptiform activity on EEG, and improved spatial learning and memory in mouse models of acute seizures and kainic acid-induced temporal lobe epilepsy. The team traced the effect to B9 suppressing the heat shock protein HSPA1A and freeing the protein AP2B1, which preserved the glutamate receptor subunit GluA2 and limited calcium overload in neurons; knocking down AP2B1 erased B9's benefits. The findings come from mice only.